
SeaSpine Holdings Corporation SPNE
Quarterly report 2022-Q3
added 11-03-2022
SeaSpine Holdings Corporation Interest Expense 2011-2026 | SPNE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense SeaSpine Holdings Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.53 M | 463 K | 302 K | -256 K | 430 K | -264 K | -877 K | -269 K | -4.56 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.53 M | -4.56 M | 56.1 K |
Quarterly Interest Expense SeaSpine Holdings Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -419 K | - | 2 K | - | -231 K | 6.08 M | -159 K | - | 136 K | 14 K | 227 K | - | -97 K | -25 K | 73 K | - | -190 K | -157 K | 20 K | - | 215 K | 185 K | -13 K | - | -59 K | -232 K | 258 K | - | 195 K | -51 K | -721 K | - | -30 K | -22 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.08 M | -721 K | 200 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 104.93 | 0.34 % | $ 183 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 167.25 | -5.68 % | $ 12.5 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.4 | 6.74 % | $ 41.1 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.08 | -3.82 % | $ 1.66 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 34.41 | -2.65 % | $ 5.13 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 69.2 | -1.38 % | $ 102 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.17 | -2.34 % | $ 260 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 35.66 | -2.67 % | $ 1.11 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Electromed
ELMD
|
78 K | $ 24.33 | -0.51 % | $ 206 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.21 | -2.64 % | $ 3.45 M | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 56.38 | -5.9 % | $ 1.67 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 79.29 | -3.42 % | $ 46.4 B | ||
|
PAVmed
PAVM
|
-10.5 M | $ 8.75 | -2.13 % | $ 63.3 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.54 | -0.03 % | $ 122 M | ||
|
InspireMD
NSPR
|
200 K | $ 1.65 | -4.75 % | $ 106 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.92 | -4.48 % | $ 1.17 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.36 | -0.21 % | $ 721 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.3 | -3.08 % | $ 168 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.63 | -1.12 % | $ 1.24 B | ||
|
Penumbra
PEN
|
893 K | $ 335.13 | -0.38 % | $ 13 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.74 | -3.73 % | $ 369 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 61.48 | -3.41 % | $ 3.35 B | ||
|
LENSAR
LNSR
|
660 K | $ 5.59 | 1.27 % | $ 64.4 M |